Futura Medical plc (LON:FUM – Get Free Report)’s share price crossed below its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of GBX 36 ($0.46) and traded as low as GBX 33.40 ($0.42). Futura Medical shares last traded at GBX 34.60 ($0.44), with a volume of 226,774 shares trading hands.
Futura Medical Stock Down 2.1 %
The business has a 50 day simple moving average of GBX 35.32 and a 200 day simple moving average of GBX 36. The company has a market capitalization of £101.08 million, a PE ratio of -3,460.00 and a beta of 1.25.
Insider Activity
In related news, insider James Henry Barder sold 250,000 shares of the firm’s stock in a transaction dated Friday, September 13th. The stock was sold at an average price of GBX 41 ($0.52), for a total transaction of £102,500 ($130,076.14). Corporate insiders own 32.14% of the company’s stock.
About Futura Medical
Futura Medical plc, a pharmaceutical company, develops pharmaceutical and healthcare products for the consumer healthcare markets focusing on sexual health and pain relief management. Its lead product is MED3000, a topical gel for the treatment of erectile dysfunction. The company also develops pain relief products, including TPR100, a topical diclofenac pain relief gel; CBD100, a topical cannabidiol formulation; and TIB200, a topical ibuprofen pain relief gel.
Featured Articles
- Five stocks we like better than Futura Medical
- Best ESG Stocks: 11 Best Stocks for ESG Investing
- Super Micro Computer Soars 28%: Is It Really Out of the Woods?
- What is a Low P/E Ratio and What Does it Tell Investors?
- Traders Are Flocking Back to Oil: What’s Fueling the Optimism
- What Are Dividends? Buy the Best Dividend Stocks
- 3 Hot Stock Trends to Ride Into 2025
Receive News & Ratings for Futura Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Futura Medical and related companies with MarketBeat.com's FREE daily email newsletter.
